Stock Events

Stock Events

Treace Medical Concepts 

$4.81
14
+$0.44+10.07% 20:00 Today
-$0.03-0.62%20:19After hours

Statistics

Day High
5.01
Day Low
4.58
52W High
7.65
52W Low
1.17
Volume
594,832
Avg. Volume
689,615
Mkt Cap
312.82M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.31
-0.21
-0.11
-0.01
Expected EPS
-0.25428
Actual EPS
N/A

Financials

-27.74%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
212.69MRevenue
-59MNet Income

Analyst Ratings

6.00Average Price Target
The highest estimate is 7.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TMCI. It's not an investment recommendation.
Amazon
6
AMZN
NVIDIA
6
NVDA
Micron Technology
4
MU
Oracle
4
ORCL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap126.37B
Stryker Corporation is a direct competitor in the medical technology and orthopedic devices sector, offering products that can compete with Treace Medical Concepts' foot and ankle surgery solutions.
Zimmer Biomet
ZBH
Mkt Cap19.26B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare, competing in the orthopedic market with products that could be used in similar procedures as those targeted by Treace Medical Concepts.
Medtronic
MDT
Mkt Cap119.49B
Medtronic plc offers a wide range of medical technologies, including orthopedic solutions that compete with Treace Medical Concepts' offerings in the surgical space.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson's medical devices segment, particularly its DePuy Synthes brand, provides orthopedic and other surgical products that compete with Treace Medical Concepts' portfolio.
Globus Medical
GMED
Mkt Cap11.67B
Globus Medical, Inc. designs, develops, and commercializes musculoskeletal solutions, which puts it in direct competition with Treace Medical Concepts in the orthopedic surgery market.
Smith & Nephew
SNN
Mkt Cap12.25B
Smith & Nephew plc offers advanced medical devices in orthopedics, among other areas, competing with Treace Medical Concepts in the global market for surgical solutions.
Alphatec
ATEC
Mkt Cap1.46B
Alphatec Holdings, Inc. is primarily focused on spine surgery solutions but competes in the broader orthopedic sector, including areas that overlap with Treace Medical Concepts' focus.
K2 Capital Acquisition
KTWO
Mkt Cap201.21M
K2M Group Holdings, Inc., before its acquisition by Stryker, specialized in innovative spine and minimally invasive solutions, competing in the orthopedic space with Treace Medical Concepts.

About

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Show more...
CEO
John T. Treace
Employees
450
Country
United States
ISIN
US89455T1097

Listings

BOATS
BOATS
TMCI.BOATS
XNAS
US
TMCI

0 Comments

Share your thoughts

FAQ

What is Treace Medical Concepts stock price today?▼
The current price of TMCI is $4.81 USD — it has increased by +10.07% in the past 24 hours. Watch Treace Medical Concepts stock price performance more closely on the chart.
What is Treace Medical Concepts stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Treace Medical Concepts stocks are traded under the ticker TMCI.
Is Treace Medical Concepts stock price growing?▼
TMCI stock has risen by +8.09% compared to the previous week, the month change is a +20.25% rise, over the last year Treace Medical Concepts has showed a -35.61% decrease.
What is Treace Medical Concepts market cap?▼
Today Treace Medical Concepts has the market capitalization of 312.82M
When is the next Treace Medical Concepts earnings date?▼
Treace Medical Concepts is going to release the next earnings report on November 10, 2026.
What were Treace Medical Concepts earnings last quarter?▼
TMCI earnings for the last quarter are -0.24 USD per share, whereas the estimation was -0.3 USD resulting in a +19.46% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Treace Medical Concepts revenue for the last year?▼
Treace Medical Concepts revenue for the last year amounts to 212.69M USD.
What is Treace Medical Concepts net income for the last year?▼
TMCI net income for the last year is -59M USD.
How many employees does Treace Medical Concepts have?▼
As of August 25, 2026, the company has 450 employees.
In which sector is Treace Medical Concepts located?▼
Treace Medical Concepts operates in the Health & Wellness sector.
When did Treace Medical Concepts complete a stock split?▼
Treace Medical Concepts has not had any recent stock splits.
Where is Treace Medical Concepts headquartered?▼
Treace Medical Concepts is headquartered in PONTE VEDRA, United States.